Skip to main content

and
  1. Article

    Open Access

    SARS-CoV-2-specific immune responses converge in kidney disease patients and controls with hybrid immunity

    Healthy individuals with hybrid immunity, due to a SARS-CoV-2 infection prior to first vaccination, have stronger immune responses compared to those who were exclusively vaccinated. However, little is known ab...

    Muriel Aguilar-Bretones, Yvette den Hartog, Laura L. A. van Dijk in npj Vaccines (2024)

  2. Article

    Open Access

    Overcoming immune checkpoint blockade resistance in solid tumors with intermittent ITK inhibition

    Cytotoxic CD8 + T cell (CTL) exhaustion is driven by chronic antigen stimulation. Reversing CTL exhaustion with immune checkpoint blockade (ICB) has provided clinical benefits in different types of cancer. We,...

    Manzhi Zhao, Ling Li, Caoimhe H. Kiernan, Melisa D. Castro Eiro in Scientific Reports (2023)

  3. Article

    Open Access

    Stratification of hospitalized COVID-19 patients into clinical severity progression groups by immuno-phenoty** and machine learning

    Quantitative or qualitative differences in immunity may drive clinical severity in COVID-19. Although longitudinal studies to record the course of immunological changes are ample, they do not necessarily predi...

    Yvonne M. Mueller, Thijs J. Schrama, Rik Ruijten in Nature Communications (2022)

  4. Article

    Open Access

    Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

    In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care to treatment with 300mL convalescent plasma containing high titers of neutralizing SARS-CoV-2 antibodies, no overall ...

    Arvind Gharbharan, Carlijn C. E. Jordans, Corine GeurtsvanKessel in Nature Communications (2021)

  5. Article

    Open Access

    Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoir

    An innovative approach to eliminate HIV-1-infected cells emerging out of latency, the major hurdle to HIV-1 cure, is to pharmacologically reactivate viral expression and concomitantly trigger intracellular pro...

    Shringar Rao, Cynthia Lungu, Raquel Crespo, Thijs H. Steijaert in Nature Communications (2021)

  6. No Access

    Article

    The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling

    The roles of individual microRNAs in the CD8+ T cell response remain mostly unexplored. Katsikis and colleagues show that miR-155 regulates type I interferon responsiveness and CD8+ T cell responses to pathogens

    Donald T Gracias, Erietta Stelekati, Jennifer L Hope in Nature Immunology (2013)

  7. No Access

    Article

    Actin integrity is indispensable for CD95/Fas-induced apoptosis of HIV-specific CD8+ T cells

    We have recently provided data suggesting a potential role for mitochondria and Bcl-2-family molecules in apoptosis sensitivity of HIV-specific CD8+ T cells. Here, we report on the role of filamentous (F) actin i...

    Constantinos Petrovas, Yvonne M. Mueller, Guibin Yang, Susan R. Altork in Apoptosis (2007)

  8. Article

    Decreased effector memory CD45RA+ CD62L- CD8+ T cells and increased central memory CD45RA- CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients

    Although a role for CD8+ T cells in the pathogenesis of rheumatoid arthritis (RA) has been suggested, the precise nature of their involvement is not fully understood. In the present study we examined the central ...

    Anastacia Maldonado, Yvonne M Mueller, Preethi Thomas, Paul Bojczuk in Arthritis Res Ther (2003)

  9. Article

    In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses

    Given the key role CD8+ T cells play in controlling viral infection, strategies to enhance these responses may have important clinical applications. We found that in vivo CD137 stimulation with an agonistic monoc...

    E. Scott Halstead, Yvonne M. Mueller, John D. Altman in Nature Immunology (2002)